The head of Johnson & Johnson (J&J) Innovation in Europe says the region is ripe for more life sciences investment, but warns that the UK, its biotech leader, could miss out withou
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
